U.S. federal trademark · Serial No. 85085616 · Reg. No. 4039477
pharmaceutical preparations for the treatment of cancer, particularly monoclonal antibodies for treatment of hematological tumors and solid cancers, and pharmaceutical preparations for the treatment of inflammatory diseases, including autoimmune diseases, immune dysregulation and transplant-related diseases, particularly monoclonal antibodies for treatment of these diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.